Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dhara N Amin

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Experimental Cell Research|June 21, 2005
Neuregulin-regulated gene expression in mammary carcinoma cellsDhara N Amin, David Tuck, David F Stern
Seminars in Cell & Developmental Biology|September 7, 2010
The role of HER3, the unpretentious member of the HER family, in cancer biology and cancer therapeuticsDhara N Amin, Marcia R Campbell, Mark M Moasser
Oncogene|February 20, 2004
Gene expression profiling of ErbB receptor and ligand-dependent transcriptionDhara N Amin, Archibald S Perkins, David F Stern
Cancer Research|February 21, 2006
Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitorsDhara N Amin, Kyoko Hida, Diane R Bielenberg, et al.
Molecular Cancer Therapeutics|October 7, 2015
A TORC2-Akt Feed-Forward Topology Underlies HER3 Resiliency in HER2-Amplified CancersDhara N Amin, Deepika Ahuja, Paul Yaswen, et al.
Oncotarget|October 31, 2015
Chemical probing of HER2-amplified cancer cells identifies TORC2 as a particularly effective secondary target for combination with lapatinibDhara N Amin, Ana Ruiz-Saenz, Nathaniel Gulizia, et al.
The Biochemical Journal|August 3, 2012
HER3 signalling is regulated through a multitude of redundant mechanisms in HER2-driven tumour cellsDhara N Amin, Natalia Sergina, Lionel Lim, et al.
Microvascular Research|April 29, 2008
Targeting EGFR activity in blood vessels is sufficient to inhibit tumor growth and is accompanied by an increase in VEGFR-2 dependence in tumor endothelial cellsDhara N Amin, Diane R Bielenberg, Eugene Lifshits, et al.
Cancer Research|April 15, 2010
Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3FSilvia Coma, Dhara N Amin, Akio Shimizu, et al.
Cancer Research|November 19, 2004
Tumor-associated endothelial cells with cytogenetic abnormalitiesKyoko Hida, Yasuhiro Hida, Dhara N Amin, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Experimental Cell Research|June 21, 2005
Neuregulin-regulated gene expression in mammary carcinoma cellsDhara N Amin, David Tuck, David F Stern
Seminars in Cell & Developmental Biology|September 7, 2010
The role of HER3, the unpretentious member of the HER family, in cancer biology and cancer therapeuticsDhara N Amin, Marcia R Campbell, Mark M Moasser
Oncogene|February 20, 2004
Gene expression profiling of ErbB receptor and ligand-dependent transcriptionDhara N Amin, Archibald S Perkins, David F Stern
Cancer Research|February 21, 2006
Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitorsDhara N Amin, Kyoko Hida, Diane R Bielenberg, et al.
Molecular Cancer Therapeutics|October 7, 2015
A TORC2-Akt Feed-Forward Topology Underlies HER3 Resiliency in HER2-Amplified CancersDhara N Amin, Deepika Ahuja, Paul Yaswen, et al.
Oncotarget|October 31, 2015
Chemical probing of HER2-amplified cancer cells identifies TORC2 as a particularly effective secondary target for combination with lapatinibDhara N Amin, Ana Ruiz-Saenz, Nathaniel Gulizia, et al.
The Biochemical Journal|August 3, 2012
HER3 signalling is regulated through a multitude of redundant mechanisms in HER2-driven tumour cellsDhara N Amin, Natalia Sergina, Lionel Lim, et al.
Microvascular Research|April 29, 2008
Targeting EGFR activity in blood vessels is sufficient to inhibit tumor growth and is accompanied by an increase in VEGFR-2 dependence in tumor endothelial cellsDhara N Amin, Diane R Bielenberg, Eugene Lifshits, et al.
Cancer Research|April 15, 2010
Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3FSilvia Coma, Dhara N Amin, Akio Shimizu, et al.
Cancer Research|November 19, 2004
Tumor-associated endothelial cells with cytogenetic abnormalitiesKyoko Hida, Yasuhiro Hida, Dhara N Amin, et al.
Pageof 2